ATE380792T1 - Verfahren zur herstellung von pyrrolidinoximen - Google Patents
Verfahren zur herstellung von pyrrolidinoximenInfo
- Publication number
- ATE380792T1 ATE380792T1 AT05708062T AT05708062T ATE380792T1 AT E380792 T1 ATE380792 T1 AT E380792T1 AT 05708062 T AT05708062 T AT 05708062T AT 05708062 T AT05708062 T AT 05708062T AT E380792 T1 ATE380792 T1 AT E380792T1
- Authority
- AT
- Austria
- Prior art keywords
- oximes
- pyrrolidine oximes
- producing pyrrolidine
- producing
- formula
- Prior art date
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title abstract 4
- -1 PYRROLIDINE OXIMES Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 208000005107 Premature Birth Diseases 0.000 abstract 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 abstract 1
- 206010036590 Premature baby Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pregnancy & Childbirth (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04100773 | 2004-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE380792T1 true ATE380792T1 (de) | 2007-12-15 |
Family
ID=34896105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05708062T ATE380792T1 (de) | 2004-02-26 | 2005-02-28 | Verfahren zur herstellung von pyrrolidinoximen |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20070197794A1 (de) |
| EP (1) | EP1725526B1 (de) |
| JP (1) | JP2007524702A (de) |
| KR (1) | KR20060124775A (de) |
| CN (1) | CN1946686A (de) |
| AT (1) | ATE380792T1 (de) |
| AU (1) | AU2005217153A1 (de) |
| BR (1) | BRPI0508059A (de) |
| CA (1) | CA2554767A1 (de) |
| CY (1) | CY1107139T1 (de) |
| DE (1) | DE602005003803T2 (de) |
| DK (1) | DK1725526T3 (de) |
| EA (1) | EA011026B1 (de) |
| ES (1) | ES2296137T3 (de) |
| IL (1) | IL177388A0 (de) |
| NO (1) | NO20064352L (de) |
| PL (1) | PL1725526T3 (de) |
| PT (1) | PT1725526E (de) |
| SI (1) | SI1725526T1 (de) |
| UA (1) | UA86226C2 (de) |
| WO (1) | WO2005082848A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2845850A1 (de) | 2013-09-10 | 2015-03-11 | ObsEva S.A. | Pyrrolidinderivate als Oxytocin/Vasopressin-V1a-Rezeptorantagonisten |
| EP2886107A1 (de) | 2013-12-17 | 2015-06-24 | ObsEva S.A. | Orale Formulierungen von Pyrrolydinderivaten |
| AU2015283133B2 (en) | 2014-07-02 | 2019-05-16 | ObsEva SA | Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime useful in methods of treating conditions related to the OT-R activity |
| WO2021165927A1 (en) * | 2020-02-21 | 2021-08-26 | Wockhardt Bio Ag | 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6329418B1 (en) * | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
| HRP20020705A2 (en) * | 2000-03-27 | 2004-12-31 | Applied Research Systems | Pharmaceutically active pyrrolidine derivatives |
| BR0211030A (pt) * | 2001-06-18 | 2004-06-22 | Applied Research Systems | Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole |
-
2005
- 2005-02-28 DE DE602005003803T patent/DE602005003803T2/de not_active Expired - Fee Related
- 2005-02-28 CA CA002554767A patent/CA2554767A1/en not_active Abandoned
- 2005-02-28 AT AT05708062T patent/ATE380792T1/de not_active IP Right Cessation
- 2005-02-28 US US10/590,813 patent/US20070197794A1/en not_active Abandoned
- 2005-02-28 DK DK05708062T patent/DK1725526T3/da active
- 2005-02-28 BR BRPI0508059-2A patent/BRPI0508059A/pt not_active IP Right Cessation
- 2005-02-28 KR KR1020067019448A patent/KR20060124775A/ko not_active Withdrawn
- 2005-02-28 EA EA200601456A patent/EA011026B1/ru not_active IP Right Cessation
- 2005-02-28 WO PCT/EP2005/050852 patent/WO2005082848A2/en not_active Ceased
- 2005-02-28 EP EP05708062A patent/EP1725526B1/de not_active Expired - Lifetime
- 2005-02-28 SI SI200530122T patent/SI1725526T1/sl unknown
- 2005-02-28 AU AU2005217153A patent/AU2005217153A1/en not_active Abandoned
- 2005-02-28 JP JP2007500229A patent/JP2007524702A/ja active Pending
- 2005-02-28 PL PL05708062T patent/PL1725526T3/pl unknown
- 2005-02-28 PT PT05708062T patent/PT1725526E/pt unknown
- 2005-02-28 ES ES05708062T patent/ES2296137T3/es not_active Expired - Lifetime
- 2005-02-28 CN CNA200580012856XA patent/CN1946686A/zh active Pending
- 2005-02-28 UA UAA200609783A patent/UA86226C2/uk unknown
-
2006
- 2006-08-09 IL IL177388A patent/IL177388A0/en unknown
- 2006-09-26 NO NO20064352A patent/NO20064352L/no not_active Application Discontinuation
-
2008
- 2008-01-14 CY CY20081100051T patent/CY1107139T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1946686A (zh) | 2007-04-11 |
| JP2007524702A (ja) | 2007-08-30 |
| KR20060124775A (ko) | 2006-12-05 |
| DE602005003803T2 (de) | 2008-12-24 |
| EP1725526B1 (de) | 2007-12-12 |
| PL1725526T3 (pl) | 2008-03-31 |
| ES2296137T3 (es) | 2008-04-16 |
| US20070197794A1 (en) | 2007-08-23 |
| SI1725526T1 (sl) | 2008-04-30 |
| DK1725526T3 (da) | 2008-03-03 |
| WO2005082848A2 (en) | 2005-09-09 |
| IL177388A0 (en) | 2006-12-10 |
| CY1107139T1 (el) | 2012-10-24 |
| AU2005217153A1 (en) | 2005-09-09 |
| UA86226C2 (en) | 2009-04-10 |
| DE602005003803D1 (de) | 2008-01-24 |
| WO2005082848A3 (en) | 2005-12-01 |
| BRPI0508059A (pt) | 2007-07-17 |
| NO20064352L (no) | 2006-09-26 |
| EP1725526A2 (de) | 2006-11-29 |
| EA011026B1 (ru) | 2008-12-30 |
| PT1725526E (pt) | 2007-12-27 |
| EA200601456A1 (ru) | 2007-02-27 |
| CA2554767A1 (en) | 2005-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE542803T1 (de) | Verfahren zur herstellung von dihydrochinazolinen | |
| ATE455763T1 (de) | Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit | |
| ATE548353T1 (de) | Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon. | |
| ATE482966T1 (de) | Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide | |
| DE03713610T1 (de) | Neue kristallformen von atorvastatin-hemicalcium und verfahren zu deren herstellung, sowie neue verfahren zur herstellung der formen i, viii und ix von atorvastatin-hemicalcium | |
| ATE444950T1 (de) | Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid | |
| ATE486841T1 (de) | Verfahren zur herstellung von pregabalin und salzen daraus | |
| ATE486857T1 (de) | Verfahren zur herstellung von telmisartan | |
| DE602006003393D1 (de) | Verfahren zur Herstellung von Synthesegas durch Dampfreformieren und partielle Oxidation | |
| DE60316152D1 (de) | Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen | |
| ATE401300T1 (de) | Verfahren zur herstellung von valsartan und vorstufen davon | |
| CY1107139T1 (el) | Μεθοδος παρασκευης πυρρολιδινοξιμων | |
| DE60308066D1 (de) | Verfahren zur herstellung von hyperpolarisiertem 129xe | |
| ATE415404T1 (de) | Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten | |
| ATE517078T1 (de) | Verfahren zur herstellung von benzophenoniminen | |
| TW200635905A (en) | Processes for producing 4-aminoquinazolines | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| ATE469141T1 (de) | Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten | |
| ATE466010T1 (de) | Verfahren zur herstellung von candesartan | |
| DE602005025002D1 (de) | Verfahren zur herstellung von brenztraubensäure | |
| DE60107292D1 (de) | Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
| ATE341558T1 (de) | Verfahren zur herstellung von topiramate | |
| ATE473213T1 (de) | Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus | |
| ATE427297T1 (de) | Verfahren zur herstellung von beta- aminopropionsaurederivaten | |
| ATE488492T1 (de) | Verfahren zur herstellung von gabapentin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1725526 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |